ReviewCureus2024
HIV-Associated Pseudoaneurysms: A Comprehensive Review.
Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A pseudoaneurysm (PSA) is a contained vascular rupture that typically occurs following catheterization, at the anastomotic site between a native artery and a synthetic graft, post-trauma, or as a result of infection. It is characterized by a hematoma surrounded by tissue, often emerging as a complication of invasive arterial interventions. In patients with HIV/AIDS, PSAs can develop due to vessel wall disruption caused by chronic inflammation, opportunistic infections (such as cytomegalovirus or tuberculosis), or the direct effects of the virus, leading to abnormal blood flow into a chamber confined by adjacent tissue. The clinical presentation of PSAs varies based on their size and location. Diagnosis can be achieved through ultrasonography with color Doppler, contrast-enhanced computed tomography (CT), magnetic resonance angiography (MRA), or digital subtraction angiography (DSA). Treatment modalities include surgery, ultrasound-guided compression, thrombin injection, and endovascular techniques. This review discusses the pathophysiology, histology, diagnosis, and therapeutic options for HIV-related PSAs. Additionally, risk factors and rare complications associated with PSAs are explored in detail.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.